BioSpace News Archive

Cochlear Implant Successfully Performed as Part of MOHAP’s Initiatives for the Year of Giving

As part of the MOHAP initiatives of the Year of Giving, a cochlear implant was successfully performed for a 12-year-old Indian girl, who suffered from sudden hearing loss for a period of two years due to a severe viral infection that damaged the cochlear nerve.

December 27, 2017
·
1 min read
Austrian Science Fund Release: Improved Nutrition for Extremely Low Birth Weight Preemies

At the neonatology ward of the Vienna General Hospital, physicians compared two mixtures of intravenous lipids for nutrition with support coming from the FWF.

December 27, 2017
·
5 min read
ProQR Announces Extraordinary General Meeting of Shareholders

All relevant documents and information for the meeting, including the notice and agenda, are or will be made available on ProQR’s website.

December 27, 2017
·
1 min read
Medigus Announces First MUSE Procedure for the Treatment of GERD Performed in Israel at Shaare-Zedek Medical Center

The MUSE system is a single-use flexible transoral stapler that merges the latest advancement in microvisual, ultrasonic and surgical stapling.

December 27, 2017
·
4 min read
Drug Development

VBL Therapeutics Announces First Patient in Pivotal Phase III Study of VB-111 in Platinum Resistant Ovarian Cancer in Collaboration With the GOG Foundation, Inc.

The OVAL study will be conducted in collaboration with the Gynecologic Oncology Group (GOG) Foundation.

December 27, 2017
·
7 min read
Novo Nordisk A/S: Share Repurchase Programme – Dec. 27, 2017

This programme is part of the overall share repurchase programme of up to DKK 17 billion to be executed during a 12-month period beginning 2 February 2017.

December 27, 2017
·
1 min read
Drug Development

Herantis Pharma Expands on Timeline for Lymfactin Studies

Patient recruitment is expected to be completed in the first quarter of 2018 instead of by the end of 2017 as previously estimated and announced.

December 27, 2017
·
3 min read
Ablynx Release: Notice in Relation to Waiver of Lock-Up Restriction

The waiver will take effect on 29 December 2017 and the securities may be sold on or after such date.

December 27, 2017
·
2 min read
Drug Development

FDA Approves Nanobiotix’s First Immuno-Oncology Trial

First Nanobiotix immuno-oncology trial will be conducted in the U.S.

December 27, 2017
·
9 min read
Pharm Country

EncrypGen Partners With Health Wizz, Codigo46

EncrypGen, which specializes in blockchain for the genetic market, today announced strategic partnerships with Health Wizz and Codigo46.

December 27, 2017
·
1 min read